Skip to Main

Krishna Srikumar is a core member of Boston Consulting Group’s Health Care and Technology Advantage practices. Since joining the firm in 2015, he has worked extensively with health care clients on their transformation agendas.

Krishna’s main area of interest is at the intersection of health care (medtech, pharma), technology, and topics related to new digital business (prescriptive digital therapeutics, analytics, product redesign, and core system transformation). He is interested in exploring how technology can be a competitive differentiator in each part of the health care value chain, and in exploring digital as a commercial excellence enabler for medtech and pharma clients. He also spent close to two years in London in the Ambassador Program, and has significant experience working with European clients.

Before coming to BCG, Krishna worked for Deloitte Consulting's strategy and analytics practice in Boston.

AREAS OF EXPERTISE

EDUCATION

  • MS, finance and technology, Kelley School of Business, Indiana University,
  • BS, honors, computer engineering, University of Mumbai

Publications and Videos

" "

For Pharmaceutical Companies, Three Steps to Value with Generative AI

New GenAI offerings can benefit virtually every aspect of an organization, boosting efficiency and productivity in areas ranging from R&D to commercial activities.
Practical Steps for Health Care Leaders in the Era of Generative AI

Practical Steps for Health Care Leaders in the Era of Generative AI

The technology is evolving rapidly, but five simple steps can help providers capitalize on GenAI to improve performance, reduce costs, and enhance the experience for patients and staff.
" "

Biopharma’s Path to Value with Generative AI

Implementing GenAI is not easy in an industry with a complex value chain and intensive regulatory oversight. Companies will wrestle with both choice and complexity.
" "

Generative AI Will Transform Health Care Sooner Than You Think

Leaders need to understand the growing range of AI applications—and how to capitalize on their potential while avoiding the risks.